$473.95
-8.13 (-1.69%)
At Close: Jun 03, 2026
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
01:27pm, Tuesday, 13'th Jan 2026
Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move production from Europe or Asia to the U.S., the medical equipment maker's CEO, Marc
Nalgene Outdoor Unveils Thrill & Motion: A High-Energy Color Collection for 2026
08:30am, Tuesday, 13'th Jan 2026
ROCHESTER, N.Y.--(BUSINESS WIRE)--Nalgene Outdoor today introduces Thrill & Motion, a dynamic new collection crafted for people who embrace an active, on-the-go lifestyle; whether exploring trails, ch
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laborat
Thermo Fisher Chief Operating Officer Michel Lagarde Leaving Company
07:08am, Monday, 12'th Jan 2026
Thermo Fisher Scientific's number-two executive, Michel Lagarde, is leaving the life-sciences giant to pursue another opportunity.
Citizens Financial Group Inc. RI Has $19.65 Million Position in Thermo Fisher Scientific Inc. $TMO
03:47am, Monday, 12'th Jan 2026
Citizens Financial Group Inc. RI grew its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 20.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities
Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026
09:41am, Saturday, 10'th Jan 2026
If a recession were to hit, it's a foregone conclusion that people won't stop taking their prescriptions, and they won't cancel major medical treatments.
The Lab Equipment Titan Trading at Half the Multiple Just Delivered Another Beat
08:57am, Saturday, 10'th Jan 2026
Danaher (NYSE: DHR) and Thermo Fisher Scientific (NYSE: TMO) both reported Q3 2025 earnings showing revenue growth around 5%, but underlying business momentum tells very different stories.
There Is a Quiet But Massive Migration Away From Tech Stocks in 2026
09:50am, Friday, 09'th Jan 2026
In the last three months of 2025, the tech sector experienced what some called a “correction”.
Duncker Streett & Co. Inc. Sells 864 Shares of Thermo Fisher Scientific Inc. $TMO
04:52am, Friday, 09'th Jan 2026
Duncker Streett and Co. Inc. reduced its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 3.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange C
Thermo Fisher Scientific Inc. $TMO Shares Sold by First Merchants Corp
04:55am, Thursday, 08'th Jan 2026
First Merchants Corp decreased its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 51.6% in the undefined quarter, according to the company in its most recent filing with the Securities and E
Cerity Partners LLC Sells 15,549 Shares of Thermo Fisher Scientific Inc. $TMO
05:04am, Wednesday, 07'th Jan 2026
Cerity Partners LLC lessened its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securitie
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 06'th Jan 2026
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thermo Fisher Scientific to Present at the J.P. Morgan 2026 Healthcare Conference
08:00am, Tuesday, 06'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr
Thermo Fisher Scientific Launches CorEvitas Obesity Registry to Advance Real-World Evidence in Treatment Outcomes
07:31am, Tuesday, 06'th Jan 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific launches CorEvitas Obesity Registry to advance real-world evidence in treatment outcomes.
WestEnd Advisors LLC Raises Holdings in Thermo Fisher Scientific Inc. $TMO
08:08am, Monday, 05'th Jan 2026
WestEnd Advisors LLC raised its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 3.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor own
Sign In
Buy TMO